Scientific Advisory Board

METAvivor's research program is advised by a team of preeminent scientists and oncologists specializing in metastatic cancer research and treatment. In addition to providing expertise regarding the research that METAvivor funds, our Research Advisory Board also supports the METAvivor patient community with up-to-date information about relevant news and progress regarding research and treatment for metastatic breast cancer.

Dr. Danny R Welch

Associate Director of Basic Science, University of Kansas Cancer Center

Dr. Young J. Lee, MD

Chief of Oncology Harbor Hospital Baltimore, Maryland

Dr. Stuart. S. Martin, PhD.

Associate Professor at the Greenebaum Cancer Center, University of Maryland, Baltimore